British-Swiss Pharmaceutical Company AstraZeneca’s Covid-19 Drug Development Hits Setback
On Tuesday, British-Swiss bio-pharmaceutical company and Coronavirus vaccine-maker AstraZeneca announced that they have experienced a hold-up in their trials of Covid-19 treatment. The multinational company has been come up with a treatment for the Coronavirus. They were in the process of making a drug that is created by combining two antibodies. AstraZeneca said in a statement that it was not successful at treating Covid-19 symptoms in the infected patients. It was actually the third and the final phase of the trial to find a cure against the virus.…
Read More